These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

742 related items for PubMed ID: 32166713

  • 1. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
    Zhao Z, Mu H, Li Y, Liu Y, Zou J, Zhu Y.
    Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
    [Abstract] [Full Text] [Related]

  • 2. Clinicopathological and prognostic significance of hypoxia-inducible factor-1α in esophageal squamous cell carcinoma: a meta-analysis.
    Ping W, Sun W, Zu Y, Chen W, Fu X.
    Tumour Biol; 2014 May; 35(5):4401-9. PubMed ID: 24425106
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in patients with bone tumor: a systematic review and meta-analysis.
    Luo D, Ren H, Zhang W, Xian H, Lian K, Liu H.
    J Orthop Surg Res; 2019 Feb 19; 14(1):56. PubMed ID: 30782196
    [Abstract] [Full Text] [Related]

  • 4. High expression of hypoxia-inducible factor 1-alpha predicts poor prognosis in pancreatic ductal adenocarcinoma: a meta-analysis and database validation protocol.
    Zoa A, Yang Y, Huang W, Yang J, Wang J, Wang H, Dong M, Tian Y.
    Transl Cancer Res; 2022 Sep 19; 11(9):3080-3091. PubMed ID: 36237265
    [Abstract] [Full Text] [Related]

  • 5. Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis.
    Méndez-Blanco C, Fernández-Palanca P, Fondevila F, González-Gallego J, Mauriz JL.
    Ther Adv Med Oncol; 2021 Sep 19; 13():1758835920987071. PubMed ID: 33613697
    [Abstract] [Full Text] [Related]

  • 6. Clinical and prognostic significance of HIF-1α overexpression in oral squamous cell carcinoma: a meta-analysis.
    Zhou J, Huang S, Wang L, Yuan X, Dong Q, Zhang D, Wang X.
    World J Surg Oncol; 2017 May 18; 15(1):104. PubMed ID: 28521842
    [Abstract] [Full Text] [Related]

  • 7. Prognostic and Clinicopathological Value of Rac1 in Cancer Survival: Evidence from a Meta-Analysis.
    Lou S, Wang P, Yang J, Ma J, Liu C, Zhou M.
    J Cancer; 2018 May 18; 9(14):2571-2579. PubMed ID: 30026856
    [Abstract] [Full Text] [Related]

  • 8. Meta-analysis of immunohistochemical expression of hypoxia inducible factor-1α as a prognostic role in gastric cancer.
    Lin S, Ma R, Zheng XY, Yu H, Liang X, Lin H, Cai XJ.
    World J Gastroenterol; 2014 Jan 28; 20(4):1107-13. PubMed ID: 24574785
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinicopathological characteristics of gynecological cancer associated with hypoxia-inducible factor 1α expression: a meta-analysis including 6,612 subjects.
    Jin Y, Wang H, Ma X, Liang X, Liu X, Wang Y.
    PLoS One; 2015 Jan 28; 10(5):e0127229. PubMed ID: 25993275
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
    Gruber G, Greiner RH, Hlushchuk R, Aebersold DM, Altermatt HJ, Berclaz G, Djonov V.
    Breast Cancer Res; 2004 Jan 28; 6(3):R191-8. PubMed ID: 15084243
    [Abstract] [Full Text] [Related]

  • 13. Hypoxia-inducible factor 1α in breast cancer prognosis.
    Wang W, He YF, Sun QK, Wang Y, Han XH, Peng DF, Yao YW, Ji CS, Hu B.
    Clin Chim Acta; 2014 Jan 20; 428():32-7. PubMed ID: 24482805
    [Abstract] [Full Text] [Related]

  • 14. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.
    Ren W, Mi D, Yang K, Cao N, Tian J, Li Z, Ma B.
    Swiss Med Wkly; 2013 Jan 20; 143():w13855. PubMed ID: 24018850
    [Abstract] [Full Text] [Related]

  • 15. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
    Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E.
    Cancer; 2003 Mar 15; 97(6):1573-81. PubMed ID: 12627523
    [Abstract] [Full Text] [Related]

  • 16. The prognostic value of hypoxia-inducible factor-1α in advanced cancer survivors: a meta-analysis with trial sequential analysis.
    Han S, Huang T, Hou F, Yao L, Wang X, Wu X.
    Ther Adv Med Oncol; 2019 Mar 15; 11():1758835919875851. PubMed ID: 31579115
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
    Yang SL, Ren QG, Wen L, Hu JL.
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun 15; 36(3):321-327. PubMed ID: 27376798
    [Abstract] [Full Text] [Related]

  • 18. Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer.
    Yamamoto Y, Ibusuki M, Okumura Y, Kawasoe T, Kai K, Iyama K, Iwase H.
    Breast Cancer Res Treat; 2008 Aug 15; 110(3):465-75. PubMed ID: 17805961
    [Abstract] [Full Text] [Related]

  • 19. Hypoxia-inducible factor 1α expression and its clinical significance in pancreatic cancer: a meta-analysis.
    Ye LY, Zhang Q, Bai XL, Pankaj P, Hu QD, Liang TB.
    Pancreatology; 2014 Aug 15; 14(5):391-7. PubMed ID: 25278309
    [Abstract] [Full Text] [Related]

  • 20. Intratumoral high endothelial venules in solid tumors: a pooled study.
    Wang B, Han Y, Liu J, Zhang X, Deng Y, Jiang Y.
    Front Immunol; 2024 Aug 15; 15():1401118. PubMed ID: 39040120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.